ZA776645B - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
ZA776645B
ZA776645B ZA00776645A ZA776645A ZA776645B ZA 776645 B ZA776645 B ZA 776645B ZA 00776645 A ZA00776645 A ZA 00776645A ZA 776645 A ZA776645 A ZA 776645A ZA 776645 B ZA776645 B ZA 776645B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
ZA00776645A
Inventor
W Grueter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA776645B publication Critical patent/ZA776645B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA00776645A 1976-11-08 1977-11-07 Pharmaceutical preparations ZA776645B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (en) 1976-11-08 1976-11-08

Publications (1)

Publication Number Publication Date
ZA776645B true ZA776645B (en) 1978-08-30

Family

ID=19728406

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00776645A ZA776645B (en) 1976-11-08 1977-11-07 Pharmaceutical preparations

Country Status (9)

Country Link
JP (1) JPS5359035A (en)
AU (1) AU3041877A (en)
BE (1) BE860526A (en)
DE (1) DE2749318A1 (en)
FR (1) FR2369841A1 (en)
IL (1) IL53318A0 (en)
LU (1) LU76150A1 (en)
NL (1) NL7712100A (en)
ZA (1) ZA776645B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919342A1 (en) * 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Cardiac active combination preparations

Also Published As

Publication number Publication date
AU3041877A (en) 1979-05-17
JPS5359035A (en) 1978-05-27
IL53318A0 (en) 1978-01-31
BE860526A (en) 1978-05-08
LU76150A1 (en) 1978-07-10
FR2369841A1 (en) 1978-06-02
NL7712100A (en) 1978-05-10
DE2749318A1 (en) 1978-05-11

Similar Documents

Publication Publication Date Title
ZA783480B (en) New pharmaceutical preparations
ZA803567B (en) Pharmaceutical preparations
ZA793542B (en) Pharmaceutical preparations
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
JPS5372814A (en) Pharmaceutical composition
ZA795039B (en) Pharmaceutical preparations
ZA796549B (en) New pharmaceutical preparations
AU3152677A (en) Pharmaceutical composition
PT67323A (en) Prolonged release pharmaceutical preparations
JPS52128357A (en) Antiitumor drug
AU2649977A (en) Pharmaceutical composition
JPS5356634A (en) Pharmaceutical composition
HU175384B (en) Insecticide preparations
JPS51130425A (en) Colddwaterrsoluble preparations
GB1541710A (en) Anthelintic preparations
JPS5325579A (en) Pharmaceutical compound
BE853569A (en) MEDICINAL PREPARATIONS
JPS5283918A (en) Pharmaceutical composition
ZA776645B (en) Pharmaceutical preparations
MY8400062A (en) Pharmaceutical preparations for venotonic use
AU3149277A (en) D-homosteroids and pharmaceutical preparation
JPS5338620A (en) Isomalin antiimold drug
ZA777335B (en) Pharmaceutical compounds